Results

Total Results: 455 records

Showing results for "neoplasms malignant neoplasm".

261. Maskedstats Nrd 2015Q1Q3 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
     October 31, 2017 - electrolyte disorders 12,927,179 0 0.00 1.00 0.24 0.43 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 12,927,179 0 0.00 1.00 0.12 0.33 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 9,988 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 6,987 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 8,696 0.07% 690 … Percent of Total 692: Radiotherapy 855 0.01% 693: Chemotherapy 53,580 0.41% 694: Lymphatic & other malignancies

262. Nrd 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
     January 01, 2014 - electrolyte disorders 14,894,613 0 0.00 1.00 0.23 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,894,613 0 0.00 1.00 0.12 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,999 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,074 0.01% 693: Chemotherapy 63,030 0.42% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 11,821 0.08% 710: Infectious & parasitic diseases including HIV w

263. Nis 2012 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
     January 01, 2012 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,296,968 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,994 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,605 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,755 0.07% 690 … Percent of Total 692: Radiotherapy 706 0.01% 693: Chemotherapy 31,632 0.43% 694: Lymphatic & other malignancies

264. Archived: Ovarian Cancer: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-1996
     January 01, 1996 - cancer appear to be more effective in reducing the size of residual tumor when ovarian cancer is detected … invasive procedures (laparoscopy or laparotomy) to rule out malignancy. … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. … Detection of malignant ovarian neoplasm[s]: a review of the literature. 1. … Elevated serum CA 125 levels prior to diagnosis of ovarian cancer neoplasia: relevance for early detection

265. Most Common Diagnoses and Procedures in U.S. Community Hospitals, 1996
     hcup-us.ahrq.gov/reports/natstats/commdx/table2a.htm
     February 11, 2011 - Secondary malignancies D37. Maintenance chemotherapy, radiotherapy D38. … Benign neoplasm of uterus D43. Appendicitis and other appendiceal conditions D44. … Cancer of bronchus, lung D61. Esophageal disorders D62. Prolapse of female genital organs D63. … Other and unspecified benign neoplasm D67. Fetopelvic disproportion, obstruction D68. … Cancer of colon D80. Other female genital disorders D81. Cancer of prostate D82.

266. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
     June 01, 2009 - 055 054 NERVOUS SYSTEM NEOPLASMS 056 056 DEG NERVOUS SYSTEM … 181 180 RESP NEOPLASMS 182 180 RESP NEOPLASMS … 375 374 DIGESTIVE MALIGNANCY 376 374 DIGESTIVE MALIGNANCY … 657 656 KIDNEY&URETER PX/NEOPLASM 658 656 KIDNEY&URETER PX/NEOPLASM … 659 659 KIDNEY&URETER PX/NON-NEOPLASM 660 659 KIDNEY&URETER PX/NON-NEOPLASM

267. DST_Draft_Protocol_Nov_4_2013_clean (2) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
     November 12, 2013 - (breast, colon, lung and prostate), and according to high prevalence versus rare cancers. … modified to the correct terminology for CINAHL, PsycINFO, EMBASE, and any other databases searched: ("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous OR hypertrophy … and after”[tiab] or interrupted time*[tiab] or time serie*[tiab] or intervention*[tiab]))) AND (("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous)) Filters:Publication

268. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-Def_Public_v24.pdf
     March 01, 2008 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 DISORDERS … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROCS EX MALIG 346 346 MALIGNANCY, MALE REPRO SYSTEM, 347 346 MALIGNANCY, MALE REPRO SYSTEM, 348

269. Maskedstats Nis 2021 Dx Pr Grps (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_DX_PR_GRPS.PDF
     January 01, 2021 - 1 0.0 0 56,663 CMR_CANCER_LEUK : Leukemia 6,666,752 0 1 0.0 0 44,924 CMR_CANCER_METS : Metastatic cancer … 6,666,752 0 1 0.0 0 184,266 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 6,666,752 0 … 1 0.0 0 1,771 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 6,666,752 0 1 0.0 0 166,567 … DXCCSR_INFnnn : Certain Infectious and Parasitic Diseases 6,666,752 0 1 0.3 0 1,698,246 DXCCSR_NEOnnn : Neoplasms … 5.37% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 252,033 3.78% NEOnnn: Neoplasms

270. Maskedstats Nis 2020 Dx Pr Grps V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_DX_PR_GRPS_V2.PDF
     January 01, 2020 - 1 0.0 0 55,003 CMR_CANCER_LEUK : Leukemia 6,471,165 0 1 0.0 0 43,478 CMR_CANCER_METS : Metastatic cancer … 6,471,165 0 1 0.0 0 180,157 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 6,471,165 0 … 1 0.0 0 1,615 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 6,471,165 0 1 0.0 0 161,111 … DXCCSR_INFnnn : Certain Infectious and Parasitic Diseases 6,471,165 0 1 0.2 0 1,540,845 DXCCSR_NEOnnn : Neoplasms … 5.49% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 298,598 4.61% NEOnnn: Neoplasms

271. Maskedstats Nis 2022 Dx Pr Grps (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_DX_PR_GRPS.PDF
     January 01, 2022 - 1 0.0 0 57,035 CMR_CANCER_LEUK : Leukemia 6,578,372 0 1 0.0 0 46,277 CMR_CANCER_METS : Metastatic cancer … 6,578,372 0 1 0.0 0 187,719 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 6,578,372 0 … 1 0.0 0 1,810 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 6,578,372 0 1 0.0 0 172,683 … DXCCSR_INFnnn : Certain Infectious and Parasitic Diseases 6,578,372 0 1 0.3 0 1,664,089 DXCCSR_NEOnnn : Neoplasms … 5.14% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 237,378 3.61% NEOnnn: Neoplasms

272. Maskedstats Nis 2019 Dx Pr Grps V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_DX_PR_GRPS_V2.PDF
     January 01, 2019 - 0.0 0 47,216 CMR_CANCER_LYMPH : Lymphoma 7,083,805 0 1 0.0 0 61,024 CMR_CANCER_METS : Metastatic cancer … 7,083,805 0 1 0.0 0 194,859 CMR_CANCER_NSITU : Solid tumor without metastasis, in situ 7,083,805 0 … 1 0.0 0 1,915 CMR_CANCER_SOLID : Solid tumor without metastasis, malignant 7,083,805 0 1 0.0 0 176,691 … DXCCSR_INFnnn : Certain Infectious and Parasitic Diseases 7,083,805 0 1 0.2 0 1,401,818 DXCCSR_NEOnnn : Neoplasms … 5.50% MUSnnn: Diseases of the Musculoskeletal System and Connective Tissue 424,694 6.00% NEOnnn: Neoplasms

273. Table1 (pdf file)
     hcup-us.ahrq.gov/reports/natstats/commdx/table1.pdf
     February 11, 2011 - Benign neoplasm of uterus [46] 190,237 33.71 0.55 0.02 3.0 2.4 $8,649 $7,798 (0.02) (0.02 … Other and unspecified benign neoplasm [47] 10,879 4.29 0.03 0.92 7.9 6.3 $18,695 $14,623 … Other and unspecified benign neoplasm [47] 10,024 14.20 0.03 2.31 8.5 5.4 $34,112 $26,597 … Other and unspecified benign neoplasm [47] 17,603 25.12 0.05 0.03 3.3 2.4 $9,065 $7,588 … Other and unspecified benign neoplasm [47] 8,188 12.57 0.02 0.11 4.2 2.8 $7,853 $6,147

274. Microsoft Word - APS_DRG_Def_Public_V21.doc (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Weights%20Manual.pdf
     January 06, 2025 - Procedure): CDRG 400 in MDC 17 (Myeloproliferative Diseases and Disorders and Poorly Differentiated Neoplasms … MDC 17 – MYELOPROLIFERATIVE DISEASES AND DISORDERS AND POORLY DIFFERENTIATED NEOPLASMS: The logic … Malignancy Codes: Diagnosis code V10.48 (history of malignancy, epididymis) is now included as a history … of malignancy code within CDRG 465 (Aftercare With History of Malignancy as Secondary Diagnosis). … MDC 17 (Myeloproliferative Diseases and Disorders and Poorly Differentiated Neoplasms): CDRG 539 (Lymphoma

275. Readmissions to U.S. Hospitals by Diagnosis, 2010 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb153.pdf
     March 01, 2013 - Excludes cancers and nonspecific CCS categories. 4 Table 2. … Excludes cancers and nonspecific CCS categories. 5 Figure 1 shows that readmission rates … , other primary 6,146 1,781 29.0 42 Secondary malignancies 177,796 44,647 25.1 43 Malignant neoplasm … without specification of site 6,636 1,670 25.2 44 Neoplasms of unspecified nature or uncertain behavior … 42,002 9,551 22.7 45 Maintenance chemotherapy, radiotherapy 126,113 82,601 65.5 46 Benign neoplasm

276. Statistical Brief #153
     hcup-us.ahrq.gov/reports/statbriefs/sb153.jsp
     April 01, 2013 - Excludes cancers and nonspecific CCS categories. Table 2. … Excludes cancers and nonspecific CCS categories. … , other primary 6,146 1,781 29.0 42 Secondary malignancies 177,796 44,647 25.1 … 43 Malignant neoplasm without specification of site 6,636 1,670 25.2 44 Neoplasms … 9,551 22.7 45 Maintenance chemotherapy, radiotherapy 126,113 82,601 65.5 46 Benign

277. Neds 2006V2 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006v2_MaskedStats_Core_Weighted.PDF
     January 01, 2019 - 965 0.00 29: Cancer of prostate 9582 0.01 30: Cancer of testis 890 0.00 31: Cancer of other male … ; other and unspecified primary 3604 0.00 42: Secondary malignancies 137580 0.11 43: Malignant neoplasm … without specification of site 4843 0.00 44: Neoplasms of unspecified nature or uncertain behavior 33568 … 0.03 45: Maintenance chemotherapy; radiotherapy 3698 0.00 46: Benign neoplasm of uterus 30192 0.03 … 47: Other and unspecified benign neoplasm 51580 0.04 48: Thyroid disorders 36347 0.03 49: Diabetes

278. Neds 2006 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006_MaskedStats_Core_Weighted.PDF
     January 01, 2006 - 1065 0.00 29: Cancer of prostate 9856 0.01 30: Cancer of testis 999 0.00 31: Cancer of other male … ; other and unspecified primary 3348 0.00 42: Secondary malignancies 134808 0.11 43: Malignant neoplasm … without specification of site 5032 0.00 44: Neoplasms of unspecified nature or uncertain behavior 32819 … 0.03 45: Maintenance chemotherapy; radiotherapy 3822 0.00 46: Benign neoplasm of uterus 31428 0.03 … 47: Other and unspecified benign neoplasm 51974 0.04 48: Thyroid disorders 38149 0.03 49: Diabetes

279. Mnpoavideotranscript (pdf file)
     hcup-us.ahrq.gov/datainnovations/clinicaldata/MNPOAvideotranscript.pdf
     September 24, 2010 - On the second hospital day, a progress note  documents the discovery of a malignant neoplasm of the lung … patient is  discharged with diagnoses of obstructive chronic bronchitis with acute  exacerbation and malignant …  neoplasm of the lower lobe of the lung.     … on screen:  Coding Study #2 – POA Coding    Michael speaking:  Final coded diagnoses include lung cancer … Both could have been coded as present on admission  because cancer is a chronic diagnosis and the exacerbation

280. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
     March 13, 2012 - Background Stage II Colon Cancer Colon cancer is a common malignancy affecting both women and … Stage II colon cancer is characterized by full-thickness tumor invasion of the bowel wall and the absence … tumors that directly penetrate to the surface of the visceral peritoneum), and IIC (T4b tumors where … Draft Search Strategy for Ovid MEDLINE 1. exp Colorectal Neoplasms/ 2. … ((colorectal or colon$ or rectal or Sigmoid) adj3 (neoplasm$ or cancer$ or carcino$ or tumo?